Coya Therapeutics (COYA) Institutional Ownership $6.72 +0.01 (+0.07%) As of 02:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Coya Therapeutics (NASDAQ:COYA)CurrentInstitutional OwnershipPercentage39.75%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$7.86MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$112.40K Get COYA Insider Trade Alerts Want to know when executives and insiders are buying or selling Coya Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data COYA Institutional Buying and Selling by Quarter Coya Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025Jane Street Group LLC26,137$169K0.0%+101.7%0.156% 5/9/2025Charles Schwab Investment Management Inc.10,000$65K0.0%N/A0.060% 5/9/2025CM Management LLC200,000$1.29M1.3%+25.0%1.196% 5/7/2025Dauntless Investment Group LLC167,378$1.08M1.3%N/A1.001% 5/6/2025AIGH Capital Management LLC1,183,780$7.66M3.2%-1.4%7.078% 2/17/2025DME Capital Management LP1,646,440$9.43M0.5%+29.2%9.853% 2/14/2025Jane Street Group LLC12,961$74K0.0%N/A0.078% 2/14/2025Northern Trust Corp28,549$164K0.0%+12.2%0.171% 2/14/2025Tower Research Capital LLC TRC5,252$30K0.0%+1,005.7%0.031% 2/13/2025XTX Topco Ltd10,299$59K0.0%N/A0.062% Get the Latest News and Ratings for COYA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coya Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025Geode Capital Management LLC150,576$863K0.0%+5.8%0.901% 2/12/2025AIGH Capital Management LLC1,201,152$6.88M2.2%+85.0%7.188% 2/7/2025CM Management LLC160,000$917K0.8%+11.1%0.958% 1/28/2025Newbridge Financial Services Group Inc.70,000$401K0.1%N/A0.419% 11/16/2024Geode Capital Management LLC142,309$918K0.0%+3.3%0.852% 10/24/2024GHP Investment Advisors Inc.26,171$169K0.0%N/A0.179% 8/9/2024Renaissance Technologies LLC16,700$101K0.0%N/A0.114% 8/1/2024Gilbert & Cook Inc.10,000$61K0.0%N/A0.068% 5/10/2024Vanguard Group Inc.847,490$8.41M0.0%+772.3%5.804% 2/15/2024Greenlight Capital Inc.1,274,026$9.44M0.5%+172.2%12.702% 2/12/2024AIGH Capital Management LLC1,031,977$7.38M2.9%+92.6%10.289% 2/9/2024Worth Venture Partners LLC92,667$687K0.4%-30.8%0.924% 11/15/2023Worth Venture Partners LLC134,006$519K0.3%-8.5%1.336% 11/13/2023AIGH Capital Management LLC535,794$2.06M1.0%-8.7%5.342% 11/7/2023CM Management LLC100,000$384K0.4%+66.7%1.005% 8/14/2023 Mirador Capital Partners LP15,361$63K0.0%N/A0.154% 8/4/2023CM Management LLC60,000$244K0.2%N/A0.603% 2/16/2023AIGH Capital Management LLC560,000$2.65M0.9%N/A5.785% (Data available from 1/1/2016 forward) COYA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of COYA shares? During the previous two years, 18 institutional investors and hedge funds held shares of Coya Therapeutics. The most heavily invested institutionals were Greenlight Capital Inc. ($9.44M), DME Capital Management LP ($9.43M), Vanguard Group Inc. ($8.41M), AIGH Capital Management LLC ($7.66M), CM Management LLC ($1.29M), Dauntless Investment Group LLC ($1.08M), and Geode Capital Management LLC ($863K).Learn more on Coya Therapeutics' institutional investors. What percentage of Coya Therapeutics' stock is owned by institutional investors? 39.75% of Coya Therapeutics' stock is owned by institutional investors. Learn more on COYA's institutional investor holdings. Which institutional investors have been buying Coya Therapeutics' stock? Of the 17 institutional investors that purchased Coya Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($1.05M), Greenlight Capital Inc. ($805.96K), Vanguard Group Inc. ($750.34K), DME Capital Management LP ($372.41K), Dauntless Investment Group LLC ($167.38K), CM Management LLC ($155.94K), and Newbridge Financial Services Group Inc. ($70K). How much institutional buying is happening at Coya Therapeutics? Institutional investors have bought a total of 1,337,393 shares in the last 24 months. This purchase volume represents approximately $7.86M in transactions. Which of Coya Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Coya Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($17.37K). How much institutional selling is happening at Coya Therapeutics? Institutional investors have sold a total of 17,372 shares in the last 24 months. This volume of shares sold represents approximately $112.40K in transactions. Related Companies CryoPort Institutional Ownership Humacyte Institutional Ownership Astria Therapeutics Institutional Ownership Prothena Institutional Ownership Rocket Pharmaceuticals Institutional Ownership Foghorn Therapeutics Institutional Ownership Monte Rosa Therapeutics Institutional Ownership Aura Biosciences Institutional Ownership Altimmune Institutional Ownership Abeona Therapeutics Institutional Ownership This page (NASDAQ:COYA) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
